Advocates Criticize Medicare Rule on Brand-Name Drugs
When Medicare beneficiaries opt for a brand-name treatment over a generic version, a Medicare rule permits health plans to charge beneficiaries a standard copayment, as well as the difference between the price of the generic and the brand-name drug. Health care advocates maintain that the rule has not been explained clearly to beneficiaries.
- "Medicare Rule Criticized as Unclear" (Appleby, USA Today, 12/3).